Pfizer is moving on over to the Hudson Yards district in Manhattan.
After announcing plans to dump its faded HQ building on East 42nd Street last fall, Pfizer set in motion a plan to find some high-end space to move into. And this morning the real estate writer at The Post says that Pfizer has its heart set on The Spiral, a skyscraper that Tishman Speyer is erecting in Hudson Yards.
There’s no word yet on whether Pfizer actually inked the lease, but Pfizer reportedly wants 800,000 square feet of the building, which is fairly close to a third of the total space in an office tower that will cost more than $3 billion to build.
A Pfizer spokesperson declined to comment to me beyond noting that “we are still in the process and expect to make an announcement either later this year or early 2018.”
Tishman Speyer has been touting the Bjarke Ingels Group design, with green spaces being dangled around a 65-story structure for dramatic effect and a touch of environmental consciousness.
Real estate columnist Steve Cuozzo says that Pfizer held back on a formal selection until after its East Midtown area was rezoned to allow a much bigger building to go into its place, making its old HQ a much more valuable location for a buyer.
Images: Tishman Speyer
The best place to read Endpoints News? In your inbox.
Full-text daily reports for those who discover, develop, and market drugs. Join 21,000+ biopharma pros who read Endpoints News by email every day.Free Subscription